Skip to content

2018 Asembia Pharmacy Summit draws record crowds

The Asembia 2018 Specialty Pharmacy Summit set a new attendance record with over 6,500 attendees last week at the Wynn and Encore here. This is the thirteenth consecutive attendance record set by Asembia, reflecting the growth in specialty pharmacy.

Table of Contents

LAS VEGAS — The Asembia 2018 Specialty Pharmacy Summit set a new attendance record with over 6,500 attendees last week at the Wynn and Encore here. This is the thirteenth consecutive attendance record set by Asembia, reflecting the growth in specialty pharmacy. Participants included senior executives and key decision makers from pharmacies, health systems, pharma/biotech manufacturers, drug wholesalers, payers, technology innovators, and other industry stakeholders. This annual Asembia customer meeting is the largest U.S. healthcare conference for specialty pharmacy.

Asembia’s four-day Summit featured a robust agenda of business seminars, educational sessions, networking events, and engaging exhibits as well as impactful presentations and panel discussions from leading industry experts. Key topics included current and future trends in specialty pharmacy: the rise of consumerism, emerging alliances, innovative technologies, and patient access solutions.

The 2018 Asembia Summit offered more than 80 educational seminars with a comprehensive cross-section of business, clinical, and financial content. This year’s General Session was moderated by CNN Political Analyst David Gregory. It featured a panel of industry experts from UCB, OptumRx, CastiaRx, and Asembia sharing insight about the disruptive forces impacting the industry. Another highlighted session included panel speakers from Drug Channels Institute, J.P. Morgan Securities and IQVIA, who provided a financial perspective of specialty pharmacy as well as a statistical industry outlook.

“The growth in attendance and increasing diversity of our annual Summit is a testament to the impact that specialty pharmacy has in the delivery of quality healthcare,” stated Robert Irene, co-founder and president of Asembia. “Our mission is to work closely with our pharmacy customers and manufacturer partners to develop collaborative solutions for this rapidly growing marketplace. The Summit is one of the many services we offer the industry and we are thankful to receive such positive feedback about this event.”

Comments

Latest